CDKN2A and neoplasm: Gene expression profiling showed that SLC31A1, LIPT2, CDKN2A, and GCSH expression was increased in tumor tissues, while NFE2L2, NLRP3, ATP7A, DLD, MTF1, and DLST expression was decreased in tumor tissues compared with normal tissues.